The elevation of IL-17A levels was more prominent in groups with declined eGFR (p < 0.0001 for NA-CKD vs. CKD−, p = 0.005 for NA-CKD vs. A-CKD− and p = 0.004 for A-CKD+ vs. CKD−). This evidence concerns the gene IL17A and chronic kidney disease.